Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy of Remifentanil in Preventing Emergence Agitation — Stella

Home/Emergence Agitation/Efficacy of Remifentanil in Preventing Emergence Agitation

View on ClinicalTrials.gov

Recruiting

Back to Emergence Agitation trials

Efficacy of Remifentanil in Preventing Emergence Agitation

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Turkey (Türkiye)

Health Sciences University Gazi Yaşargil Training and Research Hospital, Diyarbakır, Kayapınar

Key details

Sponsor

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

Enrollment target

~99 participants

Started

August 2024

Primary completion

September 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 70 Years

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.